Canalevia-CA1 (Crofelemer) Delayed-Release Tablets, 125mg

Canalevia-CA1 Crofelemer Delayed-Release Tablets

Canalevia-CA1 is a groundbreaking solution for dogs experiencing chemotherapy-induced diarrhea (CID). Its unique botanical formula, based on Crofelemer, provides targeted relief by reducing excess fluid secretion in the intestines. 

Unlike traditional medications that can upset your dog's gut flora, Canalevia-CA1 preserves the natural microbiome, ensuring gentle, effective treatment. This delayed-release tablet improves the quality of life for your dog during cancer treatment and reduces the discomfort associated with chronic diarrhea.

By addressing CID with precision, Canalevia-CA1 supports smoother chemotherapy treatments for your pet, helping them feel more comfortable without altering the necessary therapeutic effects of their cancer regimen.

Prescription items are NON-RETURNABLE and NON-REFUNDABLE.

Benefits of Canalevia-CA1

• Clinically Proven Efficacy: FDA-approved to manage CID in dogs.
• Botanically Based: Uses Crofelemer, a natural extract from the Croton lechleri tree.
• Safe for Long-Term Use: A non-addictive formula designed for extended treatment durations.
• Microbiome Friendly: It does not interfere with beneficial gut bacteria, maintains digestive balance.
• Targeted, Delayed-Release: The delayed-release mechanism ensures the active ingredient is delivered precisely where needed.
• Reduced Risk of Dehydration: By regulating fluid secretion, Canalevia-CA1 helps prevent dehydration associated with chronic diarrhea.
• Non-Opioid: Offers an alternative to opioid-based anti-diarrheal medications.
• Minimal Side Effects: Mild gastrointestinal issues may occur, but it is generally well-tolerated.
• Enhances Quality of Life: Helps manage the adverse side effects of cancer treatments, improving your dog's overall well-being.

Ingredients

• Primary Ingredient: Crofelemer 125 mg
• Secondary Ingredients: Microcrystalline cellulose, magnesium stearate, hydroxypropyl cellulose, sodium starch glycolate

How Does Canalevia-CA1 Work?

Canalevia-CA1 inhibits chloride channels in the gastrointestinal tract, reducing excessive water loss. Crofelemer's botanical properties regulate electrolyte and fluid balance without disturbing the natural digestive processes. This results in less watery stools and more controlled bowel movements, specifically helping dogs undergoing chemotherapy avoid dehydration and discomfort from chronic diarrhea.

Dosage and Administration

Always consult your veterinarian for exact dosage instructions depending on your pet's condition.

Side Effects of Canalevia-CA1 Tablets

Canalevia-CA1 is generally well-tolerated in most dogs. Mild side effects may include temporary gastrointestinal discomfort such as gas or mild constipation. If symptoms persist or worsen, consult your veterinarian immediately.

Precautions

• Use only as prescribed by your veterinarian.
• Not recommended for dogs with known allergies to Crofelemer or any other ingredient in the tablet.
• Do not administer to dogs that are pregnant or lactating without veterinary supervision.

Warnings

• Keep out of reach of children.
• Do not administer Canalevia-CA1 if your dog has pre-existing conditions affecting liver or kidney function without prior vet consultation.
• Discontinue use and seek veterinary advice if your dog shows signs of an allergic reaction such as swelling, hives, or difficulty breathing.

Storage

• Store Canalevia-CA1 in a cool, dry place at room temperature (15°C–30°C or 59°F–86°F). 
• Avoid exposure to excess moisture and direct sunlight. 
• Keep it in its original container, tightly sealed.

Shipping & Returns 

Shipping Policy: We offer all types of shipping options (Ground, Express, Priority, International) depending on the urgency of the product requirements. To know about our shipping policy in detail, click here.

Refund policy: If you face any issue with our product and want to return it, read our refund policy carefully.

FAQs - Canalevia-CA1 Tablets

Q: What is Canalevia-CA1 used for?

A: Canalevia-CA1 is used to manage chemotherapy-induced diarrhea (CID) in dogs, controlling fluid secretion in the intestines to reduce diarrhea while maintaining the gut’s natural microbiome.

Q: How long does it take for Canalevia-CA1 to show results?

A: Canalevia-CA1 generally provides relief within 24-48 hours, but the duration can vary depending on the severity of the diarrhea and the individual dog's condition.

Q: Can Canalevia-CA1 be given with other medications?

A: Yes, Canalevia-CA1 can usually be administered alongside other treatments. However, always consult with your veterinarian to ensure there are no interactions with your pet's current medications.

Q: Is Canalevia-CA1 safe for all breeds and sizes of dogs?

A: Canalevia-CA1 is considered safe for most dog breeds. Your veterinarian will determine the appropriate dose based on your dog's size, breed, and overall health.

Q: Can I use Canalevia-CA1 to treat other types of diarrhea in dogs?

A: While specifically formulated for CID, your vet may recommend Canalevia-CA1 for other chronic or severe diarrhea cases. Always use it under veterinary guidance.

Q: How should I store Canalevia-CA1?

A: Store Canalevia-CA1 at room temperature, away from moisture and direct sunlight, in its original packaging.

Q: Can Canalevia-CA1 be used for long-term diarrhea management?

A: Yes, it is non-addictive and safe for extended use, especially for dogs undergoing long-term chemotherapy treatments.

Q: What should I do if I miss a dose of Canalevia-CA1?

A: If you miss a dose, administer it as soon as you remember, unless it’s close to the time for the next dose. Do not double up on doses.

Q: Can puppies use Canalevia-CA1?

A: Canalevia-CA1 is typically recommended for adult dogs undergoing chemotherapy. Always consult your vet before using it for puppies.

Q: Can I open the tablet and mix it with food?

A: It's best to administer the tablet whole to ensure proper delayed release. If your dog has trouble swallowing, consult your vet for administration tips.

Clinical Researches

https://www.isvma.org/wp-content/uploads/2023/10/year_in_review_cancer_diagnosis_and_therapy_in_2023.pdf